Ingelvac Provenza®: A New Generation in Swine Protection

The Birth Of A New Generation In Swine Protection

Achieve unrealized pig health and performance by vaccinating growing pigs against influenza A virus in swine (IAV‑S), as early as day one.

Learn More

Protects Against the Widespread Impact Of IAV‑S On Profitability

Learn more about the
cost of respiratory pathogens

Meet The Experts

Industry experts share their perspectives on current trends, challenges, and control strategies to protect growing pigs from IAV‑S.

Watch Their Videos

National Hog Farmer IAV-S webinar

Take a closer look at the prevalence, impact, and current practices used to manage IAV-S in growing pigs.

The real cost of IAV-S

Hear from Dr. Johnson about performance loss and the widespread impact of IAV-S on profitability.

Learn more

Benefits of a live vaccine

Dr. Culhane discusses how to stimulate a good immune response in growing pigs.

Learn about LAIV

Sow versus pig vaccination

On the fence about when to vaccinate? Dr. Lowe explains the need to protect growing pigs from IAV-S.

Learn more

A practitioner's on-farm experience

Dr. Patterson shares advice for diagnosing IAV-S, setting expectations, and measuring progress.

Learn more

Intranasal administration

A single 1-mL dose stimulates mucosal immunity at the natural site of infection.

Watch the administration video

Reference: 1. Dykhuis Haden C, Painter T, Fangman T, Holtkamp D. Assessing production parameters and economic impact of swine in influenza. PRRS and Mycoplasma hyopneumoniae on finishing pigs in a large production system. In: Proceedings of the 43rd American Association of Swine Veterinarians Annual Meeting: March 10–13, 2012; Denver, CO:75–76.